Print version | PDF version | Send article | RSS feed

Generex Biotechnology receives approval from the Ministry of Health of the United Arab Emirates to sell Generex Oral-lyn T

Imperial College London Diabetes Centre receives approval to sell to patients through the diabetes centre in Abu Dhabi, United Arab Emirates

13 Dec 2007 - Generex Biotechnology Corporation announced that the Ministry of Health of the United Arab Emirates, Drugs Control Department has issued a non-objection letter to the Imperial College London Diabetes Centre to import Generex Oral-lyn, Generex's proprietary oral insulin spray product, into Abu Dhabi. The Manager of the Drugs Control Department indicated that importation of Generex Oral-lyn can be done by via the issuance of a purchase order from the Imperial College London Diabetes Centre to a drug store or pharmacy licensed by the Ministry of Health of the United Arab Emirates.
 
The Imperial College London Diabetes Centre is a state-of-the-art specialized centre which is part of the government-supported Zayed Military Hospital. An estimated total of 5,000 patients are treated at the Imperial College London Diabetes Centre which is considered a leading diabetes resource in the region. Along with Generex's Middle Eastern distributor, Leosons General Trading Company, distributor of North American healthcare products in the region, a submission was prepared and filed with the Ministry of Health, UAE which resulted in the importation approval.